BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients

BACKGROUND: The BRAF V600E and telomerase reverse transcriptase (TERT) promoter mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this retrospective cross-sectional study was to add further information regarding the prevalence of the BRAF V600E and TERT promoter mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jian, Zhang, Jing, Lu, Junliang, Gao, Jie, Ren, Xinyu, Teng, Lianghong, Duan, Huanli, Lin, Yansong, Li, Xiaoyi, Zhang, Bo, Liang, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827831/
https://www.ncbi.nlm.nih.gov/pubmed/27064992
http://dx.doi.org/10.1371/journal.pone.0153319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827831/
https://www.ncbi.nlm.nih.gov/pubmed/27064992
http://dx.doi.org/10.1371/journal.pone.0153319

Ejemplares similares